Chlamydia pneumoniae infection is associated with elevated body mass index in young men

Epidemiology and Infection

Volumn 138, Issue 9, 2010, Pages 1267-1273

  Rantala, A ^a,b   Lajunen, T ^a   Juvonen, R ^c   Bloigu, A ^a   Paldanius, M ^a   Silvennoinen Kassinen, S ^b   Peitso, A ^d   Vainio, O ^b,e   Leinonen, M ^a   Saikku, P ^b  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b UNIVERSITY OF OULU   (Finland)

^c KAINUU CENTRAL HOSPITAL   (Finland)

^d CENTRE FOR MILITARY MEDICINE   (Finland)

^e OULU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Body mass index; C reactive protein; Chlamydia

Indexed keywords

BACTERIUM ANTIBODY; C REACTIVE PROTEIN; IMMUNOGLOBULIN G;

ADOLESCENT; ADULT; ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; BODY MASS; CHLAMYDIAL PNEUMONIA; CHRONIC DISEASE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; EDUCATIONAL STATUS; FINLAND; HEALTH CARE QUALITY; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MILITARY SERVICE; OBESITY; RISK FACTOR; SEROCONVERSION; SOLDIER; ASTHMA; BLOOD; CHI SQUARE DISTRIBUTION; CHLAMYDOPHILA INFECTION; CHLAMYDOPHILA PNEUMONIAE; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; QUESTIONNAIRE; SMOKING; STATISTICAL MODEL;

ADOLESCENT; ADULT; ASTHMA; BODY MASS INDEX; C-REACTIVE PROTEIN; CHI-SQUARE DISTRIBUTION; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; FINLAND; HUMANS; IMMUNOGLOBULIN G; INFLAMMATION; LOGISTIC MODELS; MALE; OBESITY; QUESTIONNAIRES; RISK FACTORS; SMOKING;

EID: 77956635929     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268809991452     Document Type: Article

References (38)

1. Saikku P, et al. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 1988;2:983-986.
2. Leinonen M, Saikku P. Evidence for infectious agents in cardiovascular disease and atherosclerosis. Lancet Infectious Diseases 2002;2:11-17.
3. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993;259:87-91.
4. Mohamed-Ali V, et al. beta-Adrenergic regulation of IL-6 release from adipose tissue: in vivo and in vitro studies. Journal of Clinical Endocrinology and Metabolism 2001;86:5864-5869.
5. Xu H, et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. Journal of Clinical Investigation 2003;112:1821-1830.
6. Ritchie SA, Connell JM. The link between abdominal obesity, metabolic syndrome and cardiovascular disease. Nutrition, Metabolism & Cardiovascular Diseases 2007;17:319-326.
7. Ross R. Atherosclerosis - an inflammatory disease. New England Journal of Medicine 1999;340:115-126.
8. Dhurandhar NV, et al. Association of adenovirus infection with human obesity. Obesity Research 1997;5:464-469.
9. Dhurandhar NV. Infectobesity: obesity of infectious origin. Journal of Nutrition 2001;131:2794S-2797S.
10. Ekesbo R, et al. Combined seropositivity for H. pylori and C. pneumoniae is associated with age, obesity and social factors. Journal of Cardiovascular Risk 2000;7:191-195.
11. Karppinen J, et al. Chronic Chlamydia pneumoniae infection increases the risk of occlusion of lumbar segmental arteries of patients with sciatica: a 3-year follow-up study. Spine 2003;28: E284-289.
12. Dart AM, Martin JL, Kay S. Association between past infection with Chlamydia pneumoniae and body mass index, low-density lipoprotein particle size and fasting insulin. International Journal of Obesity and Related Metabolic Disorders 2002;26:464-468.
13. Danesh J, et al. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. Journal of the American Medical Association 1998;279:1477-1482.
14. Visser M, et al. Elevated C-reactive protein levels in overweight and obese adults. Journal of the American Medical Association 1999;282:2131-2135.
15. Yudkin JS, et al. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arteriosclerosis, Thrombosis, and Vascular Biology 1999;19:972-978.
16. Wang S. The microimmunofluorescence test for Chlamydia pneumoniae infection: technique and interpretation. Journal of Infectious Diseases 2000;181(Suppl. 3): S421-425.
17. Paldanius M, et al. Measurement of Chlamydia pneumoniae-specific immunoglobulin A (IgA) antibodies by the microimmunofluorescence (MIF) method: comparison of seven fluorescein-labeled anti-human IgA conjugates in an in-house MIF test using one commercial MIF and one enzyme immunoassay kit. Clinical and Diagnostic Laboratory Immunology 2003;10:8-12.
18. Taponen S, et al. Metabolic cardiovascular disease risk factors in women with self-reported symptoms of oligomenorrhea and/or hirsutism: Northern Finland Birth Cohort 1966 Study. Journal of Clinical Endocrinology and Metabolism 2004;89:2114-2118. (Pubitemid 38619839)
19. Lajunen T, et al. Chlamydial LPS and high-sensitivity CRP levels in serum are associated with an elevated body mass index in patients with cardiovascular disease. Innate Immunity 2008;14:375-382.
20. Thjodleifsson B, et al. Infections and obesity: a multinational epidemiological study. Scandinavian Journal of Infectious Diseases 2008;40:381-386.
21. Kaftan AH, Kaftan O. Coronary artery disease and infection with chlamydia pneumonia. Japanese Heart Journal 2000;41:165-172.
22. Koziolek M, et al. The association between past Chlamydia pneumoniae infection and markers of chronic inflammation in obese women. European Journal of Clinical Microbiology and Infectious Diseases 2008;27:415-421.
23. Leinonen M, Saikku P. Interaction of Chlamydia pneumoniae infection with other risk factors of atherosclerosis. American Heart Journal 1999;138: S504-506.
24. Leinonen M. Chlamydia pneumoniae and other risk factors for atherosclerosis. Journal of Infectious Diseases 2000;181(Suppl. 3): S414-416.
25. Laurila A, et al. Chronic Chlamydia pneumoniae infection is associated with a serum lipid profile known to be a risk factor for atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology 1997;17:2910-2913.
26. Atkinson RL, et al. Human adenovirus-36 is associated with increased body weight and paradoxical reduction of serum lipids. International Journal of Obesity (London) 2005;29:281-286.
27. Shi Y, et al. Chlamydophila pneumoniae inhibits differentiation of progenitor adipose cells and impairs insulin signaling. Journal of Infectious Diseases 2008;197:439-448.
28. Bouwman JJ, et al. Infection-induced inflammatory response of adipocytes in vitro. International Journal of Obesity (London) 2008;32:892-901.
29. Dhurandhar NV, et al. Increased adiposity in animals due to a human virus. International Journal of Obesity and Related Metabolic Disorders 2000;24:989-996.
30. Vangipuram SD, et al. A human adenovirus enhances preadipocyte differentiation. Obesity Research 2004;12:770-777.
31. Kalayoglu MV, Byrne GI. Induction of macrophage foam cell formation by Chlamydia pneumoniae. Journal of Infectious Diseases 1998;177:725-729.
32. Cancello R, Clement K. Is obesity an inflammatory illness? Role of low-grade inflammation and macrophage infiltration in human white adipose tissue. International Journal of Obstetrics and Gynaecology 2006;113:1141-1147.
33. Kaukoranta-Tolvanen SS, et al. Growth of Chlamydia pneumoniae in cultured human peripheral blood mononuclear cells and induction of a cytokine response. Microbial Pathogenesis 1996;21:215-221.
34. Latvala J, et al. Trends in prevalence of asthma and allergy in Finnish young men: nationwide study, 1966-2003. British Medical Journal 2005;330:1186-1187.
35. Kajosaari M. Asthma and adolescence [in Finnish]. Suomen Laakarilehti 2004;59:2135-2138.
36. Dowell SF, et al. Standardizing Chlamydia pneumoniae assays: recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada). Clinical Infectious Diseases 2001;33:492-503.
37. Peeling RW, et al. Chlamydia pneumoniae serology: interlaboratory variation in microimmunofluorescence assay results. Journal of Infectious Diseases 2000;181(Suppl 3): S426-429.
38. Paldanius M, et al. Asthmatic persons are prone to the persistence of Chlamydia pneumoniae antibodies. Diagnostic Microbiology and Infectious Disease 2007;59:117-122.